首页> 美国卫生研究院文献>Frontiers in Oncology >Plastic and Reconstructive Surgeons Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons
【2h】

Plastic and Reconstructive Surgeons Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons

机译:整形外科医师和对侧预防性乳房切除术的知识和舒适度:美国整形外科医师学会的调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Despite limited oncologic benefit, contralateral prophylactic mastectomy (CPM) rates have increased in the United States over the past 15 years. CPM is often accompanied by breast reconstruction, thereby requiring an interdisciplinary approach between breast and plastic surgeons. Despite this, little is known about plastic surgeons' (PS) perspectives of CPM. The purpose of this study was to assess PS practice patterns, knowledge of CPM oncologic benefits, and perceptions of the CPM decision-making process.>Methods: An electronic survey was sent to 2,642 members of the American Society of Plastic Surgeons (ASPS). Questions assessed demographics, practice patterns, knowledge of CPM oncologic benefits, and perceptions of the CPM decision-making process.>Results: ASPS response rate was 12.5% (n = 329). Most responders worked in private practice (69%), were male (81%) and had been in practice for ≥15 years (60%). The median number of CPM reconstructions performed per month was 2–4. Fifty-five percent of PS reported routine attendance at a breast multidisciplinary conference. Responders reported CPM discussion was most likely to be initiated by the patient (51%) followed by the breast surgeon (38%), and plastic surgeon (7.3%). According to PS, the most common reason patients choose CPM is a perceived increased contralateral cancer risk (86%). Most plastic surgeons (63%) assessed the benefits of CPM as worth the risk of additional surgery and the majority (53%) estimated the complication rate at 2X the risk of unilateral surgery. The majority (61%) of PS estimated risk of contralateral cancer in an average risk patient between <2 and 5% over 10 years, which is consistent with data reported from the current literature. Most plastic surgeons (87%) reported that there was no evidence or limited evidence for breast cancer specific survival benefit with CPM. A minority of PS (18.5%) reported discomfort with a patient's choice for CPM. Of those surgeons reporting discomfort, the most common reasons for their reservations were a concern with the risk/benefit ratio of CPM and with lack of patient understanding of expected outcomes. Common reasons for PS comfort with CPM were a respect for autonomy and non-oncologic benefits of CPM.>Discussion: To our knowledge, this is the first survey reporting PS perspectives on CPM. According to PS, CPM dialogue appears to be patient driven and dominated by a perceived increased risk of contralateral cancer. Few PS reported discomfort with CPM. While many PS acknowledge both the limited oncologic benefit of CPM and the increased risk of complications, the majority have the opinion that the benefits of CPM are worth the additional risk. This apparent contradiction may be due to an appreciation of the non-oncologic benefits CPM and a desire to respect patients' choices for treatment.
机译:>背景:尽管在肿瘤学方面的益处有限,但在过去15年中,美国对侧预防性乳房切除术(CPM)的发病率有所上升。 CPM通常伴随着乳房再造,因此需要乳房和整形外科医生之间的跨学科研究。尽管如此,对整形外科医生对CPM的看法知之甚少。这项研究的目的是评估PS的实践模式,对CPM肿瘤学益处的了解以及对CPM决策过程的认识。>方法:电子调查已发送给美国医学会的2,642名成员整形外科医生(ASPS)。这些问题评估了人口统计学,实践模式,对CPM肿瘤学益处的了解以及对CPM决策过程的认识。>结果:ASPS的响应率为12.5%(n = 329)。大多数响应者都是在私人诊所工作的(69%),是男性(81%),并且从事实践≥15年(60%)。每月执行CPM重建的中位数为2-4。 55%的PS表示在乳腺多学科会议上例行出席。响应者报告说,CPM讨论最有可能由患者(51%)发起,其次是乳房外科医生(38%)和整形外科医生(7.3%)。根据PS,患者选择CPM的最常见原因是对侧癌症风险的增加(86%)。大多数整形外科医生(63%)认为CPM的好处值得进行额外的手术,而大多数(53%)的并发症发生率是单侧手术的两倍。 PS的大多数(61%)估计10年内平均风险患者的对侧癌症风险在<2%和5%之间,这与当前文献报道的数据一致。大多数整形外科医生(87%)报告说,尚无证据或有限的证据显示CPM对乳腺癌有特定的生存获益。少数PS(18.5%)报告因患者选择CPM而感到不适。在那些报告不适的外科医生中,他们保留意见的最常见原因是担心CPM的风险/收益比以及患者对预期结局的了解不足。 PS接受CPM的常见原因是尊重CPM的自主性和非肿瘤学益处。>讨论:据我们所知,这是第一项报告PS对CPM的观点。根据PS,CPM对话似乎是由患者驱动的,并以对侧癌症的风险增加为主导。很少有PS报道对CPM感到不适。尽管许多PS都承认CPM的肿瘤学益处有限和并发症风险增加,但大多数人认为CPM的益处值得额外的风险。这种明显的矛盾可能是由于对CPM的非肿瘤学益处的理解以及对尊重患者治疗选择的渴望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号